• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乙型肝炎病毒感染的肝细胞中超感染甲型肝炎病毒。

Superinfection of hepatitis A virus in hepatocytes infected with hepatitis B virus.

机构信息

Department of Molecular Virology, Graduate School of Medicine, Chiba University, Inohana 1-8-1, Chuo-ku, Chiba 260-8677, Japan.

Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, 30-1 Oyaguchi-Kamicho, Itabashi-ku, Tokyo 173-8610, Japan;

出版信息

Int J Med Sci. 2019 Sep 20;16(10):1366-1370. doi: 10.7150/ijms.32795. eCollection 2019.

DOI:10.7150/ijms.32795
PMID:31692913
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6818197/
Abstract

Hepatitis A virus (HAV) infection is a major cause of acute hepatitis including acute liver failure. Hepatitis B infection (HBV) occurs worldwide, with the highest rates in Asian and African countries, and there are several reports that HAV infection may have a more severe clinical course in patients with chronic HBV infection. We previously demonstrated that Japanese miso extracts have inhibitory effects on HAV replication. In the present study, we examined the replication of HAV and HBV in a hepatocyte superinfection model and the inhibitory effects of Japanese miso extracts on both viruses. According to the results, HAV infection inhibited HBV replication in superinfected hepatocytes, and Japanese rice-koji miso extracts had inhibitory effects on HAV replication. Our findings provide useful information for clinicians in managing HAV infection in patients with chronic HBV infection.

摘要

甲型肝炎病毒(HAV)感染是急性肝炎的主要病因,包括急性肝衰竭。乙型肝炎病毒(HBV)感染在全球范围内发生,亚洲和非洲国家的发病率最高,有几份报告表明,在慢性 HBV 感染患者中,HAV 感染可能具有更严重的临床病程。我们之前证明日本味噌提取物对 HAV 复制具有抑制作用。在本研究中,我们在肝细胞再感染模型中检查了 HAV 和 HBV 的复制以及日本味噌提取物对这两种病毒的抑制作用。结果表明,HAV 感染抑制了再感染肝细胞中的 HBV 复制,日本米曲味噌提取物对 HAV 复制具有抑制作用。我们的研究结果为临床医生在管理慢性 HBV 感染患者的 HAV 感染方面提供了有用的信息。

相似文献

1
Superinfection of hepatitis A virus in hepatocytes infected with hepatitis B virus.乙型肝炎病毒感染的肝细胞中超感染甲型肝炎病毒。
Int J Med Sci. 2019 Sep 20;16(10):1366-1370. doi: 10.7150/ijms.32795. eCollection 2019.
2
Inhibitory effect of Japanese rice-koji miso extracts on hepatitis A virus replication in association with the elevation of glucose-regulated protein 78 expression.日本米曲味噌提取物对甲型肝炎病毒复制的抑制作用与葡萄糖调节蛋白 78 表达的升高有关。
Int J Med Sci. 2018 Jul 30;15(11):1153-1159. doi: 10.7150/ijms.27489. eCollection 2018.
3
Superinfective Hepatitis E Virus Infection Aggravates Hepatocytes Injury in Chronic Hepatitis B.重叠戊型肝炎病毒感染加重慢性乙型肝炎患者肝细胞损伤
Curr Med Sci. 2019 Oct;39(5):719-726. doi: 10.1007/s11596-019-2097-0. Epub 2019 Oct 14.
4
Suppression of hepatitis B virus replication mediated by hepatitis A-induced cytokine production.甲型肝炎诱导细胞因子产生介导的乙型肝炎病毒复制抑制
Liver. 2001 Feb;21(1):45-9. doi: 10.1034/j.1600-0676.2001.210107.x.
5
Strategies for the treatment of HBV/HDV.HBV/HDV 的治疗策略。
Eur J Pharmacol. 2018 Aug 15;833:379-391. doi: 10.1016/j.ejphar.2018.06.030. Epub 2018 Jun 21.
6
Acute, hepatitis-A super-infection in HBV carriers, or chronic liver disease related to HBV or HCV.乙肝病毒携带者的急性甲型肝炎重叠感染,或与乙肝病毒或丙肝病毒相关的慢性肝病。
Ann Trop Med Parasitol. 1999 Oct;93(7):745-51. doi: 10.1080/00034989958005.
7
Free fatty acids or high-concentration glucose enhances hepatitis A virus replication in association with a reduction in glucose-regulated protein 78 expression.游离脂肪酸或高浓度葡萄糖会增强甲型肝炎病毒复制,并伴有葡萄糖调节蛋白78表达的降低。
Biochem Biophys Res Commun. 2017 Jan 29;483(1):694-699. doi: 10.1016/j.bbrc.2016.12.080. Epub 2016 Dec 13.
8
Amantadine and Rimantadine Inhibit Hepatitis A Virus Replication through the Induction of Autophagy.金刚烷胺和金刚乙胺通过诱导自噬抑制甲型肝炎病毒复制。
J Virol. 2022 Sep 28;96(18):e0064622. doi: 10.1128/jvi.00646-22. Epub 2022 Aug 30.
9
Sofosbuvir inhibits hepatitis A virus replication in vitro assessed by a cell-based fluorescent reporter system.索磷布韦在基于细胞的荧光报告系统中抑制甲型肝炎病毒复制的体外研究。
Antiviral Res. 2018 Jun;154:51-57. doi: 10.1016/j.antiviral.2018.04.007. Epub 2018 Apr 10.
10
A virological perspective on the need for vaccination.关于疫苗接种必要性的病毒学视角。
J Viral Hepat. 2000 May;7 Suppl 1:5-6. doi: 10.1046/j.1365-2893.2000.00020.x.

引用本文的文献

1
Recent Advances in mRNA-Based Vaccines Against Several Hepatitis Viruses.基于mRNA的几种肝炎病毒疫苗的最新进展
Biol Proced Online. 2025 Jun 3;27(1):20. doi: 10.1186/s12575-025-00269-2.
2
Unveiling the Antiviral Efficacy of Forskolin: A Multifaceted In Vitro and In Silico Approach.揭示毛喉素的抗病毒功效:一种多方面的体外和计算机模拟方法。
Molecules. 2024 Feb 3;29(3):704. doi: 10.3390/molecules29030704.
3
Hepatitis a Vaccine as Opportunity of Primary Prevention for Food Handlers: A Narrative Review.甲型肝炎疫苗:食品从业人员一级预防的契机——一项叙述性综述

本文引用的文献

1
Inhibitory effect of Japanese rice-koji miso extracts on hepatitis A virus replication in association with the elevation of glucose-regulated protein 78 expression.日本米曲味噌提取物对甲型肝炎病毒复制的抑制作用与葡萄糖调节蛋白 78 表达的升高有关。
Int J Med Sci. 2018 Jul 30;15(11):1153-1159. doi: 10.7150/ijms.27489. eCollection 2018.
2
Propagation of Human Hepatocytes in uPA/SCID Mice: Producing Chimeric Mice with Humanized Liver.人肝细胞在uPA/SCID小鼠中的增殖:制备具有人源化肝脏的嵌合小鼠。
Methods Mol Biol. 2017;1506:91-100. doi: 10.1007/978-1-4939-6506-9_6.
3
Possible Involvement of Hepatitis B Virus Infection of Hepatocytes in the Attenuation of Apoptosis in Hepatic Stellate Cells.
Vaccines (Basel). 2023 Jul 21;11(7):1271. doi: 10.3390/vaccines11071271.
4
Hepatitis A: Viral Structure, Classification, Life Cycle, Clinical Symptoms, Diagnosis Error, and Vaccination.甲型肝炎:病毒结构、分类、生命周期、临床症状、诊断失误及疫苗接种
Can J Infect Dis Med Microbiol. 2023 Jan 4;2023:4263309. doi: 10.1155/2023/4263309. eCollection 2023.
5
Immune Mechanisms Underlying Hepatitis B Surface Antigen Seroclearance in Chronic Hepatitis B Patients With Viral Coinfection.乙型肝炎病毒合并感染慢性乙型肝炎患者表面抗原血清学清除的免疫机制。
Front Immunol. 2022 May 11;13:893512. doi: 10.3389/fimmu.2022.893512. eCollection 2022.
6
The global trends and regional differences in incidence and mortality of hepatitis A from 1990 to 2019 and implications for its prevention.1990 年至 2019 年全球甲型肝炎发病率和死亡率的趋势和地区差异及其预防意义。
Hepatol Int. 2021 Oct;15(5):1068-1082. doi: 10.1007/s12072-021-10232-4. Epub 2021 Aug 3.
7
Co-Occurrence of Hepatitis A Infection and Chronic Liver Disease.甲型肝炎感染与慢性肝病的共现
Int J Mol Sci. 2020 Sep 2;21(17):6384. doi: 10.3390/ijms21176384.
肝细胞的乙型肝炎病毒感染可能参与肝星状细胞凋亡的减弱过程。
PLoS One. 2016 Jan 5;11(1):e0146314. doi: 10.1371/journal.pone.0146314. eCollection 2016.
4
Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.《亚太地区乙型肝炎管理临床实践指南:2015年更新版》
Hepatol Int. 2016 Jan;10(1):1-98. doi: 10.1007/s12072-015-9675-4. Epub 2015 Nov 13.
5
Association between hepatitis B virus and MHC class I polypeptide-related chain A in human hepatocytes derived from human-mouse chimeric mouse liver.人鼠嵌合小鼠肝脏来源的人肝细胞中乙型肝炎病毒与MHC I类多肽相关链A之间的关联
Biochem Biophys Res Commun. 2015 Sep 4;464(4):1192-1195. doi: 10.1016/j.bbrc.2015.07.102. Epub 2015 Jul 23.
6
Comparison of effects of hepatitis E or A viral superinfection in patients with chronic hepatitis B.戊型或甲型肝炎病毒重叠感染对慢性乙型肝炎患者的影响比较。
Hepatol Int. 2010 Aug 1;4(3):615-20. doi: 10.1007/s12072-010-9204-4.
7
Sulfated homologues of heparin inhibit hepatitis C virus entry into mammalian cells.硫酸化肝素同系物可抑制丙型肝炎病毒进入哺乳动物细胞。
J Virol. 2007 Apr;81(8):3933-41. doi: 10.1128/JVI.02622-06. Epub 2007 Feb 7.
8
A low rate of hepatitis B virus vaccine breakthrough infections in Mongolia.蒙古乙肝病毒疫苗突破性感染率较低。
J Med Virol. 2006 Dec;78(12):1554-9. doi: 10.1002/jmv.20738.
9
An outbreak of hepatitis A virus infection with a high case-fatality rate among injecting drug users.在注射吸毒者中发生的甲型肝炎病毒感染疫情,病死率很高。
J Hepatol. 2005 Dec;43(6):958-64. doi: 10.1016/j.jhep.2005.06.012. Epub 2005 Jul 11.
10
Influence of load of hepatitis A virus on disease severity and its relationship with clinical manifestations in patients with hepatitis A.甲型肝炎病毒负荷对甲型肝炎患者疾病严重程度的影响及其与临床表现的关系。
J Gastroenterol Hepatol. 2005 Aug;20(8):1165-75. doi: 10.1111/j.1440-1746.2005.03908.x.